Clinical Trials
4 trialsNCT02609776 2026-06-05
CHRYSALIS
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04077463 2026-05-08
Chrysalis-2
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT06816992 2026-04-24
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
ORIC Pharmaceuticals
Phase 1 Recruiting
NCT06507306 2026-02-06
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Recruiting